The role of Uro-Vaxom in reducing infectious adverse effects and improving outcomes in bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer
The administration of UVX during BCG therapy in NMIBC patients was associated with reduced antibiotic use and a lower BCG discontinuation rate due to UTI, thereby improving treatment adherence. These findings highlight the potential role of UVX as a valuable adjunct to BCG therapy to optimize patient outcomes.
Authors
- Dong Deuk Kwon (ORCID: https://orcid.org/0000-0002-4544-5420)
- S.H. Cho
- Eu Chang Hwang (ORCID: https://orcid.org/0000-0002-2031-124X)
- Do Gyeong Lim (ORCID: https://orcid.org/0000-0002-5955-0758)
- Seung Il Jung (ORCID: https://orcid.org/0000-0003-4864-8175)
- Ho Seok Chung (ORCID: https://orcid.org/0000-0001-9883-1539)
Institutions
- Kwangju Christian Hospital (KR)
- Chonnam National University Hospital (KR)
Publication Details
- Journal
- Investigative and Clinical Urology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4111/icu.20250060
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mike and Josie Harper Cancer Research Institute
- Chonnam National University
- Chonnam National University Hwasun Hospital